These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 19716818

  • 21. Leucine modulates the effect of Walker factor, a proteolysis-inducing factor-like protein from Walker tumours, on gene expression and cellular activity in C2C12 myotubes.
    Gonçalves EM, Salomão EM, Gomes-Marcondes MC.
    Cytokine; 2013 Oct; 64(1):343-50. PubMed ID: 23746792
    [Abstract] [Full Text] [Related]

  • 22. Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems.
    Fanzani A, Zanola A, Rovetta F, Rossi S, Aleo MF.
    Toxicol Appl Pharmacol; 2011 Feb 01; 250(3):312-21. PubMed ID: 21074548
    [Abstract] [Full Text] [Related]

  • 23. Regulation and function of IKK and IKK-related kinases.
    Häcker H, Karin M.
    Sci STKE; 2006 Oct 17; 2006(357):re13. PubMed ID: 17047224
    [Abstract] [Full Text] [Related]

  • 24. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
    Khal J, Tisdale MJ.
    Biochem Biophys Res Commun; 2008 Oct 17; 375(2):238-40. PubMed ID: 18703014
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
    Williamson DL, Bolster DR, Kimball SR, Jefferson LS.
    Am J Physiol Endocrinol Metab; 2006 Jul 17; 291(1):E80-9. PubMed ID: 16760336
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K, Stone S, Khaodhiar L, Braverman LE, DeVito WJ.
    J Cell Biochem; 1999 Aug 01; 74(2):211-9. PubMed ID: 10404391
    [Abstract] [Full Text] [Related]

  • 31. Mechanism of induction of muscle protein degradation by angiotensin II.
    Russell ST, Wyke SM, Tisdale MJ.
    Cell Signal; 2006 Jul 01; 18(7):1087-96. PubMed ID: 16257180
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA, Owens MW, Grisham MB.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):388-95. PubMed ID: 8914937
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes.
    Smith HJ, Wyke SM, Tisdale MJ.
    Br J Cancer; 2004 May 04; 90(9):1850-7. PubMed ID: 15150589
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes.
    Smith HJ, Tisdale MJ.
    Br J Cancer; 2003 Nov 03; 89(9):1783-8. PubMed ID: 14583784
    [Abstract] [Full Text] [Related]

  • 40. Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes.
    Wyke SM, Khal J, Tisdale MJ.
    Cell Signal; 2005 Jan 03; 17(1):67-75. PubMed ID: 15451026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.